Cancel-Tassin G - Search Results

1

Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.

Karlsson Q, Brook MN, Dadaev T, Wakerell S, Saunders EJ, Muir K, Neal DE, Giles GG, MacInnis RJ, Thibodeau SN, McDonnell SK, Cannon-Albright L, Teixeira MR, Paulo P, Cardoso M, Huff C, Li D, Yao Y, Scheet P, Permuth JB, Stanford JL, Dai JY, Ostrander EA, Cussenot O, Cancel-Tassin G, Hoegel J, Herkommer K, Schleutker J, Tammela TLJ, Rathinakannan V, Sipeky C, Wiklund F, Grönberg H, Aly M, Isaacs WB, Dickinson JL, FitzGerald LM, Chua MLK, Nguyen-Dumont T; PRACTICAL Consortium; Schaid DJ, Southey MC, Eeles RA, Kote-Jarai Z. Karlsson Q, et al. Eur Urol Oncol. 2021 Aug;4(4):570-579. doi: 10.1016/j.euo.2020.12.001. Epub 2021 Jan 9. Eur Urol Oncol. 2021. PMID: 33436325 Free PMC article.

2

PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.

Cancel-Tassin G, Latil A, Valéri A, Mangin P, Fournier G, Berthon P, Cussenot O. Cancel-Tassin G, et al. Eur J Hum Genet. 2001 Feb;9(2):135-42. doi: 10.1038/sj.ejhg.5200592. Eur J Hum Genet. 2001. PMID: 11313747

3

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.

Valeri A, Cormier L, Moineau MP, Cancel-Tassin G, Azzouzi R, Doucet L, Baschet F, Cussenot I, L'Her J, Berthon P, Mangin P, Cussenot O, Morin JF, Fournier G. Valeri A, et al. J Urol. 2002 Aug;168(2):483-7. doi: 10.1016/s0022-5347(05)64663-0. J Urol. 2002. PMID: 12131293

4

A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer.

Maier C, Rösch K, Herkommer K, Bochum S, Cancel-Tassin G, Cussenot O, Häussler J, Assum G, Vogel W, Paiss T. Maier C, et al. Eur Urol. 2002 Sep;42(3):301-7. doi: 10.1016/s0302-2838(02)00280-4. Eur Urol. 2002. PMID: 12234517

5

Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.

Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, Berthon P, Cussenot O. Cancel-Tassin G, et al. Eur Urol. 2003 Oct;44(4):487-90. doi: 10.1016/s0302-2838(03)00319-1. Eur Urol. 2003. PMID: 14499686

6

Microsatellite instability in urothelial carcinoma of the upper urinary tract.

Amira N, Rivet J, Soliman H, Cancel-Tassin G, Le Duc A, Janin A, Cussenot O. Amira N, et al. J Urol. 2003 Oct;170(4 Pt 1):1151-4. doi: 10.1097/01.ju.0000086551.22844.cd. J Urol. 2003. PMID: 14501713

7

[Genetic susceptibility to prostate cancer].

Cussenot O, Cancel-Tassin G. Cussenot O, et al. Med Sci (Paris). 2004 May;20(5):562-8. doi: 10.1051/medsci/2004205562. Med Sci (Paris). 2004. PMID: 15190476 Free article. Review. French.

8

Prostate cancer genetics.

Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. Minerva Urol Nefrol. 2005 Dec;57(4):289-300. Minerva Urol Nefrol. 2005. PMID: 16247350 Review.

9

Genetic susceptibility to prostate cancer.

Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. BJU Int. 2005 Dec;96(9):1380-5. doi: 10.1111/j.1464-410X.2005.05836.x. BJU Int. 2005. PMID: 16287462 Review. No abstract available.

10

Low penetrance genetic susceptibility to kidney cancer.

Thibault F, Cancel-Tassin G, Cussenot O. Thibault F, et al. BJU Int. 2006 Oct;98(4):735-8. doi: 10.1111/j.1464-410X.2006.06351.x. BJU Int. 2006. PMID: 16978268 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page